BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Mountain Standard Time
X-LIC-LOCATION:America/Denver
BEGIN:STANDARD
DTSTART:20231105T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:MST
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20240310T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:MDT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2024 Annual Meeting by the ΊΓΙ«ΟΘΙϊ\n\nTi
 tle: Industry Therapeutic Update from argenx: Consideration of the Treatm
 ent Journey in Generalized Myasthenia Gravis (gMG): Perspectives on the U
 se of VYVGART and VYVGART HYTRULO in Adults With gMG Who Are Anti-Acetylc
 holine Receptor Antibody (AChR-Ab) Positive \n\nAccess URL: https://www.a
 an.com/MSA/Public/Events/GetEventURL/17133\n\nLearn More About This Event
 : /MSA/Public/Events/Details/17133
DTEND;TZID=Mountain Standard Time:20240415T200000
DTSTAMP:20250315T221855Z
DTSTART;TZID=Mountain Standard Time:20240415T180000
LOCATION:/MSA/Public/Events/GetEventURL/17133
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from argenx: Consideration of the
  Treatment Journey in Generalized Myasthenia Gravis (gMG): Perspectives o
 n the Use of VYVGART and VYVGART HYTRULO in Adults With gMG Who Are Anti-
 Acetylcholine Receptor Antibody (AChR-Ab) Positive
UID:d7621805-d547-456a-9bbb-234808b44b08
END:VEVENT
END:VCALENDAR